nitroglycerin has been researched along with ST Elevated Myocardial Infarction in 14 studies
Nitroglycerin: A volatile vasodilator which relieves ANGINA PECTORIS by stimulating GUANYLATE CYCLASE and lowering cytosolic calcium. It is also sometimes used for TOCOLYSIS and explosives.
nitroglycerol : A nitrate ester that is glycerol in which nitro group(s) replace the hydrogen(s) attached to one or more of the hydroxy groups.
nitroglycerin : A nitroglycerol that is glycerol in which the hydrogen atoms of all three hydroxy groups are replaced by nitro groups. It acts as a prodrug, releasing nitric oxide to open blood vessels and so alleviate heart pain.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Alprostadil is a kind of liposomal prostaglandin E1 with beneficial effects on vasodilation, platelet disaggregation and fibrinolysis." | 2.87 | Intracoronary infusion of alprostadil and nitroglycerin with targeted perfusion microcatheter in STEMI patients with coronary slow flow phenomenon. ( Ding, S; Ge, H; He, B; He, J; Kong, L; Pu, J; Sheng, X; Sun, Y, 2018) |
| "Inhalation of NO at 80 ppm for 4 h in STEMI was safe but did not reduce infarct size relative to absolute LVmass at 48-72h." | 2.87 | Nitric oxide for inhalation in ST-elevation myocardial infarction (NOMI): a multicentre, double-blind, randomized controlled trial. ( Adriaenssens, T; Belmans, A; Bennett, J; Bloch, KD; Bogaert, J; Claus, P; Desmet, W; Dubois, C; Durak, M; Goetschalckx, K; Janssens, SP; Lech, P; Lux, A; Merkely, B; Pokreisz, P; Sinnaeve, P; Szelid, Z; Toth, A; Van de Werf, F; Vandenberghe, K; Vermeersch, P; Vranckx, P; Zalewski, J; Zmudka, K, 2018) |
| "In patients with STEMI ischemia, giving nitroglycerin 10 min after aspirin dosing (compared to giving them simultaneously) leads to a greater than 20% reduction in need for additional nitroglycerin, a greater than 7% decrease in subjective pain experienced by the patient and reduced need for additional opioids." | 1.62 | The timing of administering aspirin and nitroglycerin in patients with STEMI ECG changes alter patient outcome. ( Todoroski, KB, 2021) |
| "1442 STEMI patients who underwent OCT examination of culprit lesion were included and divided into young group (age ≤50 years, n = 400) and older group (age >50 years, n = 1042)." | 1.51 | Culprit lesion morphology in young patients with ST-segment elevated myocardial infarction: A clinical, angiographic and optical coherence tomography study. ( Dai, J; Fang, C; Feng, N; Hou, J; Li, L; Liu, H; Ma, L; Ren, X; Tu, Y; Wang, J; Wang, Y; Wei, G; Xing, L; Xu, M; Yu, B; Yu, H; Zhang, S; Zhang, X, 2019) |
| "ST elevation myocardial infarction (STEMI) is a time-dependent clinical emergency." | 1.51 | Improving the prehospital management of ST elevation myocardial infarction: a national quality improvement initiative. ( Al Shaikh, L; Castle, N; Howard, I; Owen, R, 2019) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 11 (78.57) | 24.3611 |
| 2020's | 3 (21.43) | 2.80 |
| Authors | Studies |
|---|---|
| Todoroski, KB | 1 |
| Fang, C | 1 |
| Dai, J | 1 |
| Zhang, S | 1 |
| Wang, Y | 2 |
| Wang, J | 1 |
| Li, L | 1 |
| Yu, H | 1 |
| Wei, G | 1 |
| Zhang, X | 1 |
| Feng, N | 1 |
| Liu, H | 1 |
| Xu, M | 1 |
| Ren, X | 1 |
| Ma, L | 1 |
| Tu, Y | 1 |
| Xing, L | 1 |
| Hou, J | 1 |
| Yu, B | 1 |
| Sabaté, M | 1 |
| Alfonso, F | 1 |
| Cequier, A | 1 |
| Romaní, S | 1 |
| Bordes, P | 1 |
| Serra, A | 1 |
| Iñiguez, A | 1 |
| Salinas, P | 1 |
| García Del Blanco, B | 1 |
| Goicolea, J | 1 |
| Hernández-Antolín, R | 1 |
| Cuesta, J | 1 |
| Gómez-Hospital, JA | 1 |
| Ortega-Paz, L | 1 |
| Gomez-Lara, J | 1 |
| Brugaletta, S | 1 |
| Brener, MI | 1 |
| Tung, J | 1 |
| Stant, J | 1 |
| Sayan, OR | 1 |
| Suh, EH | 1 |
| Minutello, RM | 1 |
| Sharma, R | 1 |
| Brener, SJ | 1 |
| Melniker, LA | 1 |
| Moustakakis, EN | 1 |
| Neuberg, G | 1 |
| Breen, LM | 1 |
| Nutovits, R | 1 |
| Kats, Y | 1 |
| Amaranto, A | 1 |
| Pucillo, A | 1 |
| Kirtane, AJ | 1 |
| Rabbani, LE | 1 |
| Carbone, A | 1 |
| Avitabile, V | 1 |
| Golino, P | 1 |
| Nigro, G | 1 |
| Russo, V | 1 |
| Tanaka, R | 1 |
| Gatate, Y | 1 |
| Sujino, Y | 1 |
| Todo, M | 1 |
| Ohta, A | 1 |
| Shimizu, Y | 1 |
| Watanabe, A | 1 |
| Naganuma, K | 1 |
| Muramatsu, T | 1 |
| Fukushima, K | 1 |
| Nakano, S | 1 |
| Patel, P | 1 |
| Yau, C | 1 |
| Kurian, J | 1 |
| Sheng, X | 1 |
| Ding, S | 1 |
| Ge, H | 1 |
| Sun, Y | 1 |
| Kong, L | 1 |
| He, J | 1 |
| Pu, J | 1 |
| He, B | 1 |
| Janssens, SP | 1 |
| Bogaert, J | 1 |
| Zalewski, J | 1 |
| Toth, A | 1 |
| Adriaenssens, T | 1 |
| Belmans, A | 1 |
| Bennett, J | 1 |
| Claus, P | 1 |
| Desmet, W | 1 |
| Dubois, C | 1 |
| Goetschalckx, K | 1 |
| Sinnaeve, P | 1 |
| Vandenberghe, K | 1 |
| Vermeersch, P | 1 |
| Lux, A | 1 |
| Szelid, Z | 1 |
| Durak, M | 1 |
| Lech, P | 1 |
| Zmudka, K | 1 |
| Pokreisz, P | 1 |
| Vranckx, P | 1 |
| Merkely, B | 1 |
| Bloch, KD | 1 |
| Van de Werf, F | 1 |
| Krishna, K | 1 |
| Hiremath, S | 1 |
| Lakade, S | 1 |
| Davakhar, S | 1 |
| Scalone, G | 1 |
| Mariani, L | 1 |
| Aimi, A | 1 |
| Grossi, P | 1 |
| Miljak, T | 1 |
| Lohrengel, K | 1 |
| Rupp, W | 1 |
| Howard, I | 1 |
| Castle, N | 1 |
| Al Shaikh, L | 1 |
| Owen, R | 1 |
| Park, CB | 1 |
| Cho, JM | 1 |
| Kim, DH | 1 |
| Kim, CJ | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| MAGnesium-based Bioresorbable Scaffold and Vasomotor Function in Patients With Acute ST Segment Elevation Myocardial Infarction[NCT03234348] | Phase 3 | 151 participants (Actual) | Interventional | 2017-07-01 | Completed | ||
| EARLY Microvascular Dysfunction Prediction Using Quantitative Flow Ratio in ST-segment Elevation MYOcardial Infarction Patients With Pharmaco-Invasive Strategy (EARLY-MYO-QFR PI)[NCT04220736] | 200 participants (Anticipated) | Observational | 2018-01-01 | Recruiting | |||
| EARLY Microvascular Dysfunction Prediction Using Quantitative Flow Ratio After ST-segment Elevation MYOcardial Infarction (EARLY-MYO-QFR I)[NCT03780335] | 162 participants (Actual) | Observational | 2015-01-01 | Completed | |||
| EARLY Microvascular Dysfunction Assessment Using Quantitative Flow Ratio After ST-segment Elevation MYOcardial Infarction (EARLY-MYO-QFR II)[NCT03910400] | 200 participants (Anticipated) | Interventional | 2019-02-01 | Recruiting | |||
| Intracoronary Infusion of Alprostadil and Nitroglycerin With Targeted Perfusion Microcatheter in STEMI Patients With Coronary Slow Flow Phenomenon[NCT03296670] | Phase 4 | 57 participants (Actual) | Interventional | 2015-08-01 | Completed | ||
| The Effects of Nitric Oxide for Inhalation on Myocardial Infarction Size[NCT01398384] | Phase 2 | 250 participants (Actual) | Interventional | 2010-10-31 | Completed | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
3 trials available for nitroglycerin and ST Elevated Myocardial Infarction
| Article | Year |
|---|---|
Magnesium-Based Resorbable Scaffold Versus Permanent Metallic Sirolimus-Eluting Stent in Patients With ST-Segment Elevation Myocardial Infarction: The MAGSTEMI Randomized Clinical Trial.
Topics: Absorbable Implants; Acetylcholine; Aged; Angioplasty, Balloon, Coronary; Coronary Angiography; Coro | 2019 |
Intracoronary infusion of alprostadil and nitroglycerin with targeted perfusion microcatheter in STEMI patients with coronary slow flow phenomenon.
Topics: Aged; Alprostadil; Catheters; Double-Blind Method; Drug Delivery Systems; Female; Humans; Infusions, | 2018 |
Intracoronary infusion of alprostadil and nitroglycerin with targeted perfusion microcatheter in STEMI patients with coronary slow flow phenomenon.
Topics: Aged; Alprostadil; Catheters; Double-Blind Method; Drug Delivery Systems; Female; Humans; Infusions, | 2018 |
Intracoronary infusion of alprostadil and nitroglycerin with targeted perfusion microcatheter in STEMI patients with coronary slow flow phenomenon.
Topics: Aged; Alprostadil; Catheters; Double-Blind Method; Drug Delivery Systems; Female; Humans; Infusions, | 2018 |
Intracoronary infusion of alprostadil and nitroglycerin with targeted perfusion microcatheter in STEMI patients with coronary slow flow phenomenon.
Topics: Aged; Alprostadil; Catheters; Double-Blind Method; Drug Delivery Systems; Female; Humans; Infusions, | 2018 |
Intracoronary infusion of alprostadil and nitroglycerin with targeted perfusion microcatheter in STEMI patients with coronary slow flow phenomenon.
Topics: Aged; Alprostadil; Catheters; Double-Blind Method; Drug Delivery Systems; Female; Humans; Infusions, | 2018 |
Intracoronary infusion of alprostadil and nitroglycerin with targeted perfusion microcatheter in STEMI patients with coronary slow flow phenomenon.
Topics: Aged; Alprostadil; Catheters; Double-Blind Method; Drug Delivery Systems; Female; Humans; Infusions, | 2018 |
Intracoronary infusion of alprostadil and nitroglycerin with targeted perfusion microcatheter in STEMI patients with coronary slow flow phenomenon.
Topics: Aged; Alprostadil; Catheters; Double-Blind Method; Drug Delivery Systems; Female; Humans; Infusions, | 2018 |
Intracoronary infusion of alprostadil and nitroglycerin with targeted perfusion microcatheter in STEMI patients with coronary slow flow phenomenon.
Topics: Aged; Alprostadil; Catheters; Double-Blind Method; Drug Delivery Systems; Female; Humans; Infusions, | 2018 |
Intracoronary infusion of alprostadil and nitroglycerin with targeted perfusion microcatheter in STEMI patients with coronary slow flow phenomenon.
Topics: Aged; Alprostadil; Catheters; Double-Blind Method; Drug Delivery Systems; Female; Humans; Infusions, | 2018 |
Intracoronary infusion of alprostadil and nitroglycerin with targeted perfusion microcatheter in STEMI patients with coronary slow flow phenomenon.
Topics: Aged; Alprostadil; Catheters; Double-Blind Method; Drug Delivery Systems; Female; Humans; Infusions, | 2018 |
Intracoronary infusion of alprostadil and nitroglycerin with targeted perfusion microcatheter in STEMI patients with coronary slow flow phenomenon.
Topics: Aged; Alprostadil; Catheters; Double-Blind Method; Drug Delivery Systems; Female; Humans; Infusions, | 2018 |
Intracoronary infusion of alprostadil and nitroglycerin with targeted perfusion microcatheter in STEMI patients with coronary slow flow phenomenon.
Topics: Aged; Alprostadil; Catheters; Double-Blind Method; Drug Delivery Systems; Female; Humans; Infusions, | 2018 |
Intracoronary infusion of alprostadil and nitroglycerin with targeted perfusion microcatheter in STEMI patients with coronary slow flow phenomenon.
Topics: Aged; Alprostadil; Catheters; Double-Blind Method; Drug Delivery Systems; Female; Humans; Infusions, | 2018 |
Intracoronary infusion of alprostadil and nitroglycerin with targeted perfusion microcatheter in STEMI patients with coronary slow flow phenomenon.
Topics: Aged; Alprostadil; Catheters; Double-Blind Method; Drug Delivery Systems; Female; Humans; Infusions, | 2018 |
Intracoronary infusion of alprostadil and nitroglycerin with targeted perfusion microcatheter in STEMI patients with coronary slow flow phenomenon.
Topics: Aged; Alprostadil; Catheters; Double-Blind Method; Drug Delivery Systems; Female; Humans; Infusions, | 2018 |
Intracoronary infusion of alprostadil and nitroglycerin with targeted perfusion microcatheter in STEMI patients with coronary slow flow phenomenon.
Topics: Aged; Alprostadil; Catheters; Double-Blind Method; Drug Delivery Systems; Female; Humans; Infusions, | 2018 |
Nitric oxide for inhalation in ST-elevation myocardial infarction (NOMI): a multicentre, double-blind, randomized controlled trial.
Topics: Administration, Inhalation; Aged; Cyclic GMP; Double-Blind Method; Female; Free Radical Scavengers; | 2018 |
11 other studies available for nitroglycerin and ST Elevated Myocardial Infarction
| Article | Year |
|---|---|
The timing of administering aspirin and nitroglycerin in patients with STEMI ECG changes alter patient outcome.
Topics: Aspirin; Electrocardiography; Humans; Nitroglycerin; Retrospective Studies; ST Elevation Myocardial | 2021 |
Culprit lesion morphology in young patients with ST-segment elevated myocardial infarction: A clinical, angiographic and optical coherence tomography study.
Topics: Adult; Aged; Coronary Angiography; Female; Heart; Humans; Image Processing, Computer-Assisted; Male; | 2019 |
An Updated Healthcare System-Wide Clinical Pathway for Managing Patients With Chest Pain and Acute Coronary Syndromes.
Topics: Acute Coronary Syndrome; Adrenergic beta-Antagonists; Angina, Unstable; Anticoagulants; Chest Pain; | 2019 |
ST-elevation during head up tilt test: a challenging case in syncope unit.
Topics: Administration, Sublingual; Aftercare; Aged; Coronary Angiography; Coronary Vasospasm; Electrocardio | 2020 |
Acute Myocardial Infarction in an Adolescent Receiving Anagrelide for Essential Thrombocythemia with Underlying Persistent Coronary Endothelial Dysfunction.
Topics: Acetylcholine; Adolescent; Coronary Angiography; Coronary Vessels; Echocardiography; Endothelium, Va | 2020 |
ST elevation myocardial infarction after coronary artery spasm with no clear trigger.
Topics: Amlodipine; Arrhythmias, Cardiac; Cardiopulmonary Resuscitation; Coronary Angiography; Coronary Vaso | 2017 |
Acute Myocardial Infarction in Nephrotic Syndrome.
Topics: Adult; Anterior Wall Myocardial Infarction; Coronary Angiography; Coronary Vessels; Fibrinolytic Age | 2015 |
Coronary epicardic vasospasm in patient treated with desatinib for lymphoblastic leukaemia: the other side of the medal.
Topics: Aged; Coronary Angiography; Coronary Vasospasm; Dasatinib; Electrocardiography; Humans; Male; Nitrog | 2019 |
[A Rare Cause of Acute Coronary Occlusion with Inferior ST-Elevation Myocardial Infarction and Out of Hospital Cardiac Arrest].
Topics: Coronary Angiography; Coronary Occlusion; Female; Humans; Middle Aged; Nitroglycerin; Out-of-Hospita | 2019 |
Improving the prehospital management of ST elevation myocardial infarction: a national quality improvement initiative.
Topics: Aspirin; Clopidogrel; Electrocardiography; Emergency Medical Services; Guideline Adherence; Humans; | 2019 |
Intracoronary nitroglycerin injection through a microcatheter for coronary no-reflow following percutaneous coronary intervention.
Topics: Humans; Injections; Male; Middle Aged; Nitroglycerin; No-Reflow Phenomenon; Percutaneous Coronary In | 2016 |